Perspective Therapeutics (NYSE:CATX) Earns Outperform Rating from Wedbush
Perspective Therapeutics (NYSE:CATX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities researchers at Wedbush in a report issued on Thursday,RTT News reports. They currently have a $11.00 price target on the stock, down from their prior price target of $20.00. Wedbush’s price target suggests a potential upside of 265.45% from the […]
More Stories
2 Dead, 3 Injured in Shooting at Reno Casino; Suspect In Custody
By Tom Ozimek A man opened fire outside a Reno casino in Nevada on the morning of July 28, killing...
Top 10 Travel Management Software: Review in 2025
Anybody who has experience traveling for work knows that it is very difficult to maintain a record. Travel management software...
Zach Justice’s Bio: Age, Relationship, Movies, and Net Worth
Zach Justice is an American actor, content creator, and comedian, and is best known among fans for his funny skits...
Delta Co-Pilot Got Arrested Moments After Landing, Over Child Porn Charges
On 26 July 2025, Saturday, a Delta Airlines flight from Minneapolis to San Francisco landed around 9:35 p.m. after being...
‘Ransom Canyon’ Season 2 Release Date, Cast, & More
A new season of Ransom Canyon has been officially announced. This Texas-based romance show, starring Minka Kelly and Josh Duhamel,...
Nick Kurtz Hits 4 Home Runs: Athletics’ Rookie’s Historic Night By The Numbers
By FOX Sports Not 1. Not 2. Not 3. But, yes, FOUR freaking home runs were hit by Athletics rookie first baseman Nick...